Page last updated: 2024-08-26

cyproterone acetate, ethinyl estradiol drug combination and Metabolic Syndrome

cyproterone acetate, ethinyl estradiol drug combination has been researched along with Metabolic Syndrome in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Demirlenk, S; Karabulut, A; Sevket, O1

Other Studies

1 other study(ies) available for cyproterone acetate, ethinyl estradiol drug combination and Metabolic Syndrome

ArticleYear
Effects of ethinyl estradiol-cyproterone acetate treatment on metabolic syndrome, fat distribution and carotid intima media thickness in polycystic ovary syndrome.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2012, Volume: 28, Issue:4

    Topics: Adiposity; Adolescent; Adult; Androgen Antagonists; Body Fat Distribution; Carotid Intima-Media Thickness; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Insulin Resistance; Metabolic Syndrome; Polycystic Ovary Syndrome; Testosterone; Young Adult

2012